Decrease in early mortality for newly diagnosed multiple myeloma patients in the Netherlands: a population-based study
Abstract Identification of risk factors for early mortality (EM) in multiple myeloma (MM) patients may contribute to different therapeutic approaches in patients at risk for EM. This population-based study aimed to assess trends in EM and risk factors for EM among MM patients diagnosed in the Nether...
Guardado en:
Autores principales: | Mirian Brink, Kaz Groen, Pieter Sonneveld, Monique C. Minnema, Annemiek Broijl, Avinash G. Dinmohamed, Ellen van der Spek, Mark-David Levin, Paula F. Ypma, Esther de Waal, Eduardus F. M. Ward Posthuma, Sonja Zweegman, Niels W. C. J. van de Donk |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/10e01658db454831b4b2e5e6af5592ee |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Predicting treatment benefit in multiple myeloma through simulation of alternative treatment effects
por: Joske Ubels, et al.
Publicado: (2018) -
Risk of second primary malignancies in patients with follicular lymphoma: a population-based study in the Netherlands, 1989-2018
por: Manette A. W. Dinnessen, et al.
Publicado: (2021) -
A Systematic Review of Cost-Effectiveness Analyses of Novel Agents in the Treatment of Multiple Myeloma
por: Maarten R. Seefat, et al.
Publicado: (2021) -
Planning in the Netherlands Antilles
por: van Trikt, Humphrey, et al.
Publicado: (2020) -
Liposomal drug delivery in an in vitro 3D bone marrow model for multiple myeloma
por: Braham MVJ, et al.
Publicado: (2018)